(Total Views: 393)
Posted On: 08/03/2019 2:57:20 AM
Post# of 153986
Yes , this is from March 2018 , Dr Lindner name was there already..
I didn’t noticed. or remembered this ..
People complain about Dr NP , but he has a lot of smartness , from the beginning he associate our company with accomplished scientist ..
And after yesterday PR I understood why they continue pre-clinical studies in colon cancer , they still looking for different MOA for Leronlimab ..
Observation that Leronlimab is inhibiting angiogenesis is really important , this is at least one of the reason it is affecting tumors with high and low CCR5 expression ..
Yes as Zuess said September and October should really be interesting , BLA hopefully will be done , and sometimes mid/end of September we should have pre-clinical results in NASH ..
I am also hoping for better enrollment in TNBC , and probably results in some of the patients 21 days later ...
I didn’t noticed. or remembered this ..
People complain about Dr NP , but he has a lot of smartness , from the beginning he associate our company with accomplished scientist ..
And after yesterday PR I understood why they continue pre-clinical studies in colon cancer , they still looking for different MOA for Leronlimab ..
Observation that Leronlimab is inhibiting angiogenesis is really important , this is at least one of the reason it is affecting tumors with high and low CCR5 expression ..
Yes as Zuess said September and October should really be interesting , BLA hopefully will be done , and sometimes mid/end of September we should have pre-clinical results in NASH ..
I am also hoping for better enrollment in TNBC , and probably results in some of the patients 21 days later ...
(0)
(0)
